Over the next several months on this blog I will be covering a new series on the “Design and Implementation of an Effective Potent Compound Safety Program.” This series will largely follow the content of the article that was published by Dr. Joe Nieusma and myself in the October, 2007 issue of ContractPharma. In this series I will cover the following topics:
Anticipation: understanding the drug development process, conducting a preliminary risk assessment, literature sources, and potent compound categorization.
Recogniton: recognizing activities with exposure potential, recognizing hazards of active pharmaceutical ingredients (APIs)
Evaluation: conducting a walkthrough survey, industrial hygiene monitoring for APIs, wipe sampling, etc.
Control: control banding in the pharmaceutical industry, engineering controls, administrative controls, and personal protective equipment.
Throughout this series we will go into greater detail and depth than what was possible in the magazine. In addition, where possible we will provide links to technical resources that are within the public domain.
Click on any of the above links for specific times and to register. If you have any questions about our webinars please contact Affygility Solutions.